Myoma - 78 Studies Found

Recruiting : Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
: Pulmonary Lymphangioleiomyomatosis
: 2016-03-31
: Drug: saracatinib Subjects will receive enough tablets for 90 days +/- 14 days at each visit. Subject wi
Completed : Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis
: Lymphangioleiomyomatosis
: 2012-08-02
: Drug: sirolimus and hydroxychloroquine This will be a phase I dose escalation study of the combination o
Completed : Pulmonary Hypertension in Lymphangioleiomyomatosis
:
  • Lymphangioleiomyomatosis
  • Pulmonary Hypertension

: 2009-08-17
Completed : Doxycycline In Lymphangioleiomyomatosis (LAM)
:
  • Lymphangioleiomyomatosis
  • Tuberous Sclerosis

: 2009-10-02
:
  • Drug: Doxycycline 50mg od
Recruiting : Safety and Durability of Sirolimus for Treatment of LAM
: Lymphangioleiomyomatosis
: 2015-03-04
:
  • Drug: Sirolimus Sirolimus trea
Not yet recruiting : LAM Pilot Study With Imatinib Mesylate
: Lymphangioleiomyomatosis
: 2017-04-24
:
  • Drug: Imatinib Mesylate 400Mg Capsule

Recruiting : Safety of Simvastatin in LAM and TSC
:
  • Lymphangioleiomyomatosis
  • Tuberous Sclerosis Complex

: 2014-01-23
: Drug: Simvastatin Eligible patients will be assigned to receive 20 mg of simvastatin once daily for a pe
Recruiting : COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC
: Lymphangioleiomyomatosis (LAM)
: 2015-06-25
: Drug: Celecoxib We will perform a pilot clinical trial to investigate the safety and tolerability of cel
Completed : Lymphangioleiomyomatosis (LAM) Registry
:
  • Lung Diseases
  • Lymphangiomyomatosis

: 2000-05-25
Not yet recruiting : Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial
: Dyspnea
: 2017-05-10
: Drug: Sirolimus mTOR inhibitor or placebo Other Name
<<< Previous | Next >>>